Post by
westcoast1000 on Oct 05, 2022 3:30pm
New results?
Let us hope (and it is reasonable expect) that these presentations offer more information and results than the three person trial result announced last spring.
Comment by
Spdstr on Oct 05, 2022 4:31pm
Oncolytics will host a key opinion leader (KOL) webinar to discuss the current treatment landscape and unmet medical need in pancreatic cancer, as well as the interim GOBLET study results that will be presented at the SITC conference
Comment by
Buckhenry on Oct 05, 2022 4:45pm
they will say that pela is well tolerated in lab rats and we need further studies.......
Comment by
jimsenior on Oct 06, 2022 7:37am
I think the following may address CPI alone with chemotherapy.. Search: Combination Immunotherapy for Pancreatic Cancer: challenges and considerations.
Comment by
cardu on Oct 06, 2022 10:36am
If the results show an extension of the 3 person tumour reduction published last sping, it will be explosive. Also the mice results that someone called a CURE!